Parkinson’s disease is an illness which arises from a clinical motor dysfunction caused by dopamine depletion in the striatum following a reduction of the large dopaminergic neurons located in the substantia nigra. There has been numerous studies on effective treatment for Parkinson’s although so far none has been discovered to successfully prevent or slow down its progression. We are able to hypothesize that autologus neural stem cells (NSCs) have the potential for stem cell therapy to effectively treat Parkinson’s Diseases.
This is because the NSC’s are not associated with any ethical issues which are linked to the use of human fetal tissue or embryonic stem cells. Because the NSC’s are derived from adult tissue, this procedure also allows autologous transplantation to occur because the patient allows NSC’s to be extracted from him and it can be modified through expansion and differentiation which can then be re-implanted back in the form of dopaminergic precursor cells.
Stem Cell Treatment or Therapy is intended as an improvement on ones condition. It is not a “cure all” or “miracle pill.” The doctors have performed hundreds of procedures with great results and results will vary according to each individual patient!